ResMed, LifeScan agree to co-market
By HME News Staff
Updated Mon June 30, 2008
POWAY, Calif., and MILPITAS, Calif.--ResMed and LifeScan in June announced an exclusive co-marketing agreement targeted at people with sleep-disordered breathing and Type 2 diabetes. The partnership comes on the heels of a recently released consensus statement from the International Diabetes Federation (IDF) that links obstructive sleep apnea and Type 2 diabetes. The companies will focus on educational and cross-promotional efforts.
Comments